ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Veterinary Epidemiology and Economics

Canine parvovirus and canine distemper virus antibody dynamics in Philippine puppies during a commercial vaccination program

  • 1. Cebu Technological University, Cebu, Philippines

  • 2. HIPRA Philippines, Muntinlupa City, Philippines

  • 3. HIPRA SA, Amer, Spain

  • 4. Pet Family Animal Clinic and Grooming Center, Imus, Cavite, Philippines

  • 5. PhilVets Veterinary Products Trading Corp., CEBU CITY, Philippines

  • 6. University of the Philippines Manila, Manila, Philippines

The final, formatted version of the article will be published soon.

Abstract

Core vaccination is central to puppy preventive care, but longitudinal canine parvovirus (CPV) and canine distemper virus (CDV) serological data from Philippine field settings remain limited. This prospective, single-arm field evaluation enrolled 61 client-owned puppies aged 6–8 weeks at two veterinary clinics and followed them across five scheduled visits. Serum was collected before vaccination at Visits 1–4 and two weeks after the final vaccination at Visit 5. Puppies received Hipradog-DP at Visit 1, Hipradog-DHLP at Visit 2, and Hipradog-7 at Visits 3 and 4. CPV IgG was measured by indirect ELISA and expressed as a log2-derived manufacturer antibody index; CDV IgG was expressed as optical density (OD). Samples were tested in duplicate, serial samples from the same puppy were analysed within the same analytical run, and manufacturer-defined laboratory interpretations were retained. Specimens with questionable analytical results together with poor specimen quality were excluded from the primary analysis. Follow-up was incomplete: samples were available for 51 puppies at Visit 5, of which 30 had valid results for each assay. CPV seropositivity increased from 45.0% (27/60) at baseline to 100.0% (30/30) at Visit 5, while CDV seropositivity increased from 33.9% (20/59) to 100.0% (30/30). Continuous CPV values differed across visits among 30 complete cases (Friedman χ²(4)=44.83, p<0.001), and repeated CPV serostatus also changed (Cochran Q=54.05, p<0.001). CDV OD differed across visits among 29 complete cases (Friedman χ²(4)=37.74, p<0.001). A broader sensitivity analysis showed the same significant temporal pattern, although final seropositivity was 94.0% for CPV and 92.0% for CDV. These findings support favourable humoral response dynamics during the observed vaccination programme. However, laboratory quality-based exclusions, the uncontrolled design, short follow-up, and use of binding-antibody ELISAs preclude inference of vaccine efficacy or individual protective immunity.

Summary

Keywords

Canine distemper virus, Canine parvovirus, core vaccination, ELISA, Field evaluation, Maternally derived antibodies, Puppies, Serostatus

Received

25 July 2026

Accepted

18 September 2026

Copyright

© 2026 Ybañez, Tolentino, Sánchez Díaz, Baratelli, Morato, Mirasol, Ybanez and Ulanday. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Adrian Patalinghug Ybañez

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics